White House science/tech proposals may fit Capitol Hill 'cures' goals
This article was originally published in Scrip
Two lawmakers leading an effort on Capitol Hill to find solutions for accelerating the discovery, development and delivery processes for new medicines want to know whether recommendations made nearly two years ago by President Barack Obama's science and technology advisers would work for the House Energy & Commerce Committee’s 21st Century Cures Initiative.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.